Embecta Corp. (EMBC) Stock Analysis & Investment Frameworks
Embecta Corp. (EMBC) stock analysis on Invetso. Review Embecta Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Embecta Corp. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
Embecta Corp. Key Financial Metrics
- Market Cap: $380.19M
- Revenue: $1.08B
- P/E Ratio: 3.99
- ROE: -13.98%
- ROIC: 17.81%
- Dividend Yield: 4.77%
About Embecta Corp.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Embecta Corp. Investment Frameworks
Invetso analyzes Embecta Corp. (EMBC) across the following frameworks:
- Embecta Corp. 10Y Growth Potential
- Embecta Corp. Scenario Analysis
- Embecta Corp. Risks & Opportunities
- Embecta Corp. Economic Moat
- Embecta Corp. Business Model
- Embecta Corp. Management
- Embecta Corp. SWOT Analysis
- Embecta Corp. Porter's 5 Forces
- Embecta Corp. PESTLE Analysis
- Embecta Corp. ESG Analysis